AU2001266932A1 - Human lyases - Google Patents

Human lyases

Info

Publication number
AU2001266932A1
AU2001266932A1 AU2001266932A AU6693201A AU2001266932A1 AU 2001266932 A1 AU2001266932 A1 AU 2001266932A1 AU 2001266932 A AU2001266932 A AU 2001266932A AU 6693201 A AU6693201 A AU 6693201A AU 2001266932 A1 AU2001266932 A1 AU 2001266932A1
Authority
AU
Australia
Prior art keywords
lyases
human
human lyases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001266932A
Other languages
English (en)
Inventor
Mariah R. Baughn
Neil Burford
Ameena R. Gandhi
Danniel B. Nguyen
Chandra Patterson
Jayalaxmi Ramkumar
Kavitha Thangavelu
Michael Thornton
Catherine M. Tribouley
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001266932A1 publication Critical patent/AU2001266932A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001266932A 2000-06-23 2001-06-13 Human lyases Abandoned AU2001266932A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US21338300P 2000-06-23 2000-06-23
US60/213,383 2000-06-23
US21554400P 2000-06-30 2000-06-30
US60/215,544 2000-06-30
US22281800P 2000-08-04 2000-08-04
US60/222,818 2000-08-04
PCT/US2001/019166 WO2002000840A2 (fr) 2000-06-23 2001-06-13 Lyases humaines

Publications (1)

Publication Number Publication Date
AU2001266932A1 true AU2001266932A1 (en) 2002-01-08

Family

ID=27395860

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001266932A Abandoned AU2001266932A1 (en) 2000-06-23 2001-06-13 Human lyases

Country Status (5)

Country Link
EP (1) EP1292685A2 (fr)
JP (1) JP2004501632A (fr)
AU (1) AU2001266932A1 (fr)
CA (1) CA2381338A1 (fr)
WO (1) WO2002000840A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002236595A1 (en) * 2000-12-07 2002-06-18 Incyte Genomics, Inc. Enzymes
AU2002238483A1 (en) * 2001-01-03 2002-07-16 Bayer Aktiengesellschaft Regulation of human ornithine decarboxylase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988004688A1 (fr) * 1986-12-23 1988-06-30 Howard Florey Institute Of Experimental Physiology Isoenzyme d'anhydrase carbonique
US5972684A (en) * 1997-11-25 1999-10-26 Incyte Pharmaceuticals, Inc. Carbonic anhydrase VIII
JP2002541801A (ja) * 1999-04-09 2002-12-10 ヒューマン ジノーム サイエンシーズ, インコーポレイテッド 48個のヒト分泌タンパク質
WO2001062927A2 (fr) * 2000-02-24 2001-08-30 Incyte Genomics Inc Molecules utilisees a des fins diagnostiques et therapeutiques

Also Published As

Publication number Publication date
WO2002000840A2 (fr) 2002-01-03
CA2381338A1 (fr) 2002-01-03
EP1292685A2 (fr) 2003-03-19
WO2002000840A3 (fr) 2002-08-08
JP2004501632A (ja) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2001255522A1 (en) Mri-resistant implantable device
AU9517301A (en) Implant
AU2000267458A1 (en) Hypercomputer
AU2001263841A1 (en) Implant
GB0009591D0 (en) Medical combinations
AU2001220246A1 (en) Neckphone
AU2001259702A1 (en) Tissue regrafting
AU2001268525A1 (en) Human kinases
AU2001238488A1 (en) Human kinases
AU2001288612A1 (en) Human kinases
AU2001277959A1 (en) Human kinases
AU2371201A (en) Endoscope
AU2002227925A1 (en) Human beta-defensin-3
AU2001270129A1 (en) Human phosphodiesterases
AU2001255573A1 (en) Human kinases
AU2002227352A1 (en) Human kinases
GB0030541D0 (en) Medical uses
AU2002358719A1 (en) Agaricoglycerides and analogs
AUPR069500A0 (en) Tissue modification
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001266932A1 (en) Human lyases
AU2002219846A1 (en) Novel use
AU2001292897A1 (en) Novel therapy
AU6286101A (en) New use
GB2358857B (en) Coffins